215 related articles for article (PubMed ID: 30764737)
1.
Zhou Y; Li J; Xu X; Zhao M; Zhang B; Deng S; Wu Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830758. PubMed ID: 30764737
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
Shokeen M; Anderson CJ
Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
[TBL] [Abstract][Full Text] [Related]
4. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.
Anderson CJ; Ferdani R
Cancer Biother Radiopharm; 2009 Aug; 24(4):379-93. PubMed ID: 19694573
[TBL] [Abstract][Full Text] [Related]
5. The development of copper radiopharmaceuticals for imaging and therapy.
Shokeen M; Wadas TJ
Med Chem; 2011 Sep; 7(5):413-29. PubMed ID: 21711219
[TBL] [Abstract][Full Text] [Related]
6. Copper radionuclides and radiopharmaceuticals in nuclear medicine.
Blower PJ; Lewis JS; Zweit J
Nucl Med Biol; 1996 Nov; 23(8):957-80. PubMed ID: 9004284
[TBL] [Abstract][Full Text] [Related]
7. High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers.
Jørgensen JT; Persson M; Madsen J; Kjær A
Nucl Med Biol; 2013 Apr; 40(3):345-50. PubMed ID: 23394821
[TBL] [Abstract][Full Text] [Related]
8. Radiocopper for the imaging of copper metabolism.
Hueting R
J Labelled Comp Radiopharm; 2014 Apr; 57(4):231-8. PubMed ID: 24634197
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in copper radiopharmaceuticals.
Hao G; Singh AN; Oz OK; Sun X
Curr Radiopharm; 2011 Apr; 4(2):109-21. PubMed ID: 22191650
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of copper-64 radiopharmaceuticals as cancer theranostics.
Boschi A; Martini P; Janevik-Ivanovska E; Duatti A
Drug Discov Today; 2018 Aug; 23(8):1489-1501. PubMed ID: 29635027
[TBL] [Abstract][Full Text] [Related]
11. Exploring pitfalls of
Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
[TBL] [Abstract][Full Text] [Related]
12. Copper chelation chemistry and its role in copper radiopharmaceuticals.
Wadas TJ; Wong EH; Weisman GR; Anderson CJ
Curr Pharm Des; 2007; 13(1):3-16. PubMed ID: 17266585
[TBL] [Abstract][Full Text] [Related]
13. ImmunoPET Imaging of α
White JB; Hu LY; Boucher DL; Sutcliffe JL
Mol Imaging Biol; 2018 Feb; 20(1):103-113. PubMed ID: 28653240
[TBL] [Abstract][Full Text] [Related]
14. Enantiopure bifunctional chelators for copper radiopharmaceuticals--does chirality matter in radiotracer design?
Singh AN; Dakanali M; Hao G; Ramezani S; Kumar A; Sun X
Eur J Med Chem; 2014 Jun; 80():308-15. PubMed ID: 24793881
[TBL] [Abstract][Full Text] [Related]
15. [PET radiopharmaceuticals: novelties and new possibilities].
Környei J; Mikecz P; Tóth G
Magy Onkol; 2014 Dec; 58(4):245-50. PubMed ID: 25517442
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals.
Ferreira CL; Yapp DT; Lamsa E; Gleave M; Bensimon C; Jurek P; Kiefer GE
Nucl Med Biol; 2008 Nov; 35(8):875-82. PubMed ID: 19026949
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive Detection of HER2 Expression in Gastric Cancer by
Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
[TBL] [Abstract][Full Text] [Related]
18. A comparison of PET imaging characteristics of various copper radioisotopes.
Williams HA; Robinson S; Julyan P; Zweit J; Hastings D
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1473-80. PubMed ID: 16258764
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of radiometal-labeled proteins and peptides: what are the real radiopharmaceuticals in vivo?
Anderson CJ
Cancer Biother Radiopharm; 2001 Dec; 16(6):451-5. PubMed ID: 11789022
[No Abstract] [Full Text] [Related]
20. PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.
Paterson BM; Roselt P; Denoyer D; Cullinane C; Binns D; Noonan W; Jeffery CM; Price RI; White JM; Hicks RJ; Donnelly PS
Dalton Trans; 2014 Jan; 43(3):1386-96. PubMed ID: 24202174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
